111 research outputs found
Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
It seems well established that CpG oligonucleotides Th1 biased adjuvant activity
can be improved when closely associated with a variety of antigens in, for example,
microparticles. In this context, we prepared 1-μm near non-charged PLGA 502 or
PLGA 756 microparticles that loaded with high efficiency an antigen (50% ovalbumin
(OVA), approximately) into their matrix and CpG-chitosan complexes (near to 20%)
onto their surface maintaining OVA and CpG integrity intact. In the intradermal
immunization studies, whereas OVA microencapsulated into PLGA 756 alone induced
a strong humoral immune response assisted by a very clear Th1 bias
(IgG2a/IgG1=0.875) that was decreased by CpG co-delivery (IgG2a/IgG1=0.55), the
co-encapsulation of CpG with OVA in PLGA 502 particles significantly improved the
antibody response and isotype shifting (IgG2a/IgG1=0.73) in comparison with mice
immunized with OVA loaded PLGA 502 (IgG2a/IgG1=0). This improvement was not
correlated with the cellular immune response where the effect of co-encapsulated CpG
was rather negative (2030.2 pg/mL and 335.3 pg/mL IFN-g for OVA PLGA 502 for
OVA CpG PLGA 502, respectively). These results underscore the critical role of
polymer nature and microparticle characteristics to show the benefits of coencapsulating
CpG motifs in close proximity with an antigen
Five-year randomized controlled clinical study comparing cemented and screw-retained zirconia-based implant-supported single crowns
OBJECTIVES
To compare screw-retained and cemented all-ceramic implant-supported single crowns regarding biological and technical outcomes over a 5-year observation period.
MATERIALS AND METHODS
In 44 patients, 44 two-piece dental implants were placed in single-tooth gaps in the esthetic zone. Patients randomly received a screw-retained (SR) or cemented (CR) all-ceramic single crown and were then re-examined annually up to 5 years. Outcome measures included: clinical, biological, technical, and radiographic parameters. Data were statistically analyzed with Wilcoxon-Mann-Whitney, Wilcoxon, and Fisher's exact tests.
RESULTS
During the observation period, three patients (6.8%) were loss to follow-up. Eight restorations (18.2%, CI (8.2%, 32.7%)) were lost due to technical (6 patients, 13.6% (CI (5.2%, 27.4%)), 2 CR and 4 SR group, intergroup p = .673; implants still present) or biological complications (2 patients, 4.5% (CI (0.6%, 16.5%)), only CR group, intergroup p = .201, both implants lost). This resulted in a survival rate of 81.2% (CI (65.9%, 90.1%)) on the restorative level (18 SR; 15 CR, 3 lost to follow-up). At the 5-year follow-up, the median marginal bone levels were located slightly apical relative to the implant shoulder with 0.4 mm (0.5; 0.3) (SR) and 0.4 mm (0.8; 0.3) (CR) (intergroup p = .582). Cemented restorations demonstrated a significantly higher biological complication rate (36.8%, SR: 0.0%; intergroup p = .0022), as well as a significantly higher overall complication rate (68.4%, SR: 22.7%, intergroup p = .0049). All other outcomes did not differ significantly between the two groups (p > .05).
CONCLUSIONS
All-ceramic single-tooth restorations on two-piece dental implants resulted in a relatively low survival rate. Cemented restorations were associated with a higher biological and overall complication rate than screw-retained restorations
Sustainable unfired bricks manufacturing from construction and demolition wastes
The management of construction and demolition wastes is a huge challenge for most Governments. Thegreatest component of such wastes is concrete and masonry fragments or remains. Among the most com-mon approaches to valorization of such w astes is to convert them to recycled aggregates, however thismay be hampered by low quality of some recycled aggregates compared to natural aggregates. This paperpresents the results of experimental investigation where concrete and ceramic remains were used to par-tially substitute clay soil in producing unfired bricks. The bricks were then tested for mechanical strength,water absorption freeze-thaw resistance. Additionally the environmental impact of the bricks wasassessed based on Life Cycle Analysis (LCA). It was established that concrete waste could be used to sub-stitute up to 50% of the clay whereas ceramic wastes could only substitute a maximum of 30% of the clay.Blended bricks made from clay and concrete waste mixes had a lower mechanical strength than thosemade from clay and ceramic waste. As regards water absorption, there was no marked differencebetween the two blends of brick however reduction in water resistance was slightly greater in bricks con-taining concrete waste that in those containing ceramic wastes. Also, tests showed that freeze-thawresistance was greater in bricks blended with concrete wastes than in those incorporating ceramicwastes. Life Cycle analyses demonstrated that it is the binder content in the mix that largely determinesthe environmental impact of the blended bricks. Lastly, it was demonstrated that the most desirable tech-nical and environmental credentials of brick material mixes resulted from using the binder combination:CL-90-S+GGBS 2/8
In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188
A micellar formulation of amphotericin B (AmB) solubilized with poloxamer 188 was evaluated against an
AmB Leishmania donovani-resistant line. A concave isobologram showed a synergistic effect of this association
against promastigotes. This result was confirmed with amastigotes since the 50% effective concentration of the
new formulation was 100 times less than that of the control AmB formulation
Bioadhesive properties of Gantrez nanoparticles
Bioadhesive nanoparticles have been proposed as carriers for the oral delivery of poorly available drugs and facilitate the use of this route. This work summarises some experiments describing the bioadhesive potential of Gantrez nanoparticles fluorescently labeled with rhodamine B isothiocyanate. The adhesive potential of Gantrez was found to be stronger when folded as nanoparticles than in the solubilised form. Conventional nanoparticles displayed a tropism for the upper areas of the gastrointestinal tract, with a maximum of adhesion 30 min post-administration and a decrease in the adhered fraction along the time depending on the given dose. The cross-linkage of nanoparticles with increasing amounts of 1,3-diaminopropane stabilised the resulting carriers and prolonged their half-life in an aqueous environment; although, the adhesive capacity of nanoparticles, the intensity and the relative duration of the adhesive interactions within the gut as a function of the cross-linking degree. Finally, nanoparticles were coated with either gelatin or albumin. In the first case, the presence of gelatin dramatically decreased the initial capacity of these carriers to interact with the gut mucosa and the intensity of these phenomenons. In the latter, bovine serum albumin coated nanoparticles (BSA-NP) showed an important tropism for the stomach mucosa without further significant distribution to other parts of the gut mucosa
Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study
Purpose: The objective of this work was to evaluate the effect in the immune response produced by CpG oligodeoxynucleotides (ODN) co-encapsulated with the antigen ovalbumin (OVA) within poly(lactic-co-glycolic) acid (PLGA) 502 and 752 microparticles (MP). Methods: MP were prepared by blending 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) with PLGA and Total Recirculation One Machine System (TROMS) technology and contained OVA along with CpG sequences associated to DOTAP. After confirming the integrity of both encapsulated molecules, BALB/c mice were immunized with the resulting MP and OVA-specific antibodies and cytokine production were assessed in order to determine the immunological profile induced in mice. Results: One m near non-charged MP co-encapsulated very efficiently both OVA and CpG ODN. The release of both OVA and CpG was slow and incomplete irrespective of polymer. The results of the immune response induced in BALB/c mice indicated that, depending on the PLGA polymer used, co-encapsulation did not improve the immunogenicity of the antigen, compared either with the simply co-administration of both antigen and CpG, or with the microencapsulated antigen. Thus, mice immunized with OVA associated to PLGA 756 displayed an IgG2a characterized response which was biased to an IgG1 profile in case of CpG co-encapsulation. On the contrary, the co-encapsulation of CpG with OVA into PLGA 502 significantly improved the isotype shifting in comparison with the one showed by mice immunized with OVA loaded PLGA 502. Conclusion: This study underlines the importance of MP characteristics to fully exploit simultaneous antigen and CpG ODN particulate delivery as effective vaccine construct
Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice
Objective: To study the toxicity and activity of two new amphotericin B formulations: poly(ε-caprolactone)
nanospheres coated with poloxamer 188 (AmB-NP) and mixed micelles with the same surfactant (AmB-MM).
Materials and methods: The toxicity of these formulations was evaluated in erythrocytes, J774.2 macrophages
and LLCPK1 renal cells, as well as in mice. Activity was determined in clinical isolates and in neutropenic
mice. Mice were made neutropenic with 5-fluorouracil, infected with Candida albicans and treated
with the antifungal formulations for three consecutive days. AmB association in cells and accumulation in
kidneys and liver of animals was quantified by HPLC.
Results: Both formulations decreased between 8- and 10-fold the MIC of the polyene against clinical isolates
of C. albicans. However, their activity was lower than or equal to that of AmB-deoxycholate when it was
assessed against C. albicans-infected macrophages. When given as a single intravenous dose in mice,
AmB-MM and AmB-NP had an LD50 of 9.8 and 18.6 mg/kg, respectively, compared with 4 mg/kg for AmBdeoxycholate.
Comparison of residual infection burdens in the liver and kidneys showed that AmB-deoxycholate
(0.5 mg/kg) was more effective and faster in eradicating yeast cells than polymeric formulations.
This fact can be related to a lower AmB accumulation inside macrophages and in liver and kidneys (about 1.5
mg drug/g tissue) of mice, compared with those detected for AmB-deoxycholate (4 mg drug/g). Overall, the
efficacy of these formulations at 2 mg/kg was equal to that of AmB-deoxycholate at 0.5 mg/kg.
Conclusions: AmB-MM and AmB-NP decreased the in vivo antifungal activity of AmB, and higher concentrations
were therefore necessary to obtain a similar therapeutic effect. However, these higher concentrations
were achievable owing to the reduced toxicity of these formulations
Library of Seleno-Compounds as Novel Agents against Leishmania Species
The in vitro leishmanicidal activities of a series of 48 recently synthesized selenium derivatives against Leishmania infantum and Leishmania braziliensis parasites were tested using promastigotes and intracellular amastigote forms. The cytotoxicity of the tested compounds for J774.2 macrophage cells was also measured in order to establish their selectivity. Six of the tested compounds (compounds 8, 10, 11, 15, 45, and 48) showed selectivity indexes higher than those of the reference drug, meglumine antimonate (Glucantime), for both Leishmania species; in the case of L. braziliensis, compound 20 was also remarkably selective. Moreover, data on infection rates and amastigote numbers per macrophage showed that compounds 8, 10, 11, 15, 45, and 48 were the most active against both Leishmania species studied. The observed changes in the excretion product profile of parasites treated with these six compounds were also consistent with substantial cytoplasmic alterations. On the other hand, the most active compounds were potent inhibitors of Fe superoxide dismutase (Fe-SOD) in the two parasite species considered, whereas their impact on human CuZn-SOD was low. The high activity, low toxicity, stability, low cost of the starting materials, and straightforward synthesis make these compounds appropriate molecules for the development of affordable antileishmanicidal agents
Nanoparticules muco-pénétrantes: véhicules pour l’administration orale du paclitaxel
Paclitaxel is an anticancer drug used as solution for perfusion for the treatment of certain types of cancers. In the last years, a number of strategies have been proposed for the development of an oral formulation of this drug. However, this task is quite complicated due to the poor aqueous solubility of paclitaxel as well as the fact that this compound is substrate of the intestinal P-glycoprotein and the cytochrome P450 enzymatic complex. In this work, we have developed pegylated nanoparticles with mucopenetrating properties in order to conduct paclitaxel onto the surface of the enterocyte. These nanoparticles displayed a size of about 180 nm and a drug loading close to 15% by weight. The pharmacokinetic study in mice has shown that these nanoparticles were capable to offer therapeutic plasma levels of paclitaxel up to 72 hours. In addition, the oral relative bioavailability of paclitaxel when loaded in nanoparticles pegylated with poly(ethylene glycol) 2000 (PEG) was found to be 85%. In a subcutaneous model of tumour in mice, these pegylated nanoparticles administered orally every 3 days have demonstrated a similar efficacy than Taxol® administered intravenously every day during 9 days. All of these results suggested that these pegylated nanoparticles were capable to cross the mucus layer of the gut and, then, reach the surface of the enterocytes. The PEG molecules would facilitate the adhesion of nanoparticles to this epithelial surface, minimise the pre-systemic metabolism of paclitaxel and, thus, promote its absorption
- …